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tality were ventricular arrhythmias (OR:70.74, CI [14.298-349.99]; p<0.001),
anemia [OR: 5.61, CI [1.27-24.66]; p:0.022] and renal impairment with creat-
inine levels > 130 μmol/l (OR: 5.99; CI[1.37-26.18], p:0.017)
Conclusions: These data suggest that, in an STEMI population, glycemia
at admission is a short prognostic marker, accurately predicting both death and
survival post STEMI.
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Introduction: The syntax score (SS) was developed in 2005 by the team
of the Rotterdam Thorax Center to characterize the complexity of the coronary
network by taking into account:
1/ the number of lesions and their impact on function,
2/ the location of the lesions, and
3/ theircomplexity. However, patients in this study had multivessel disease
and stable angina. In patients with acute myocardial infarction (AMI), we
aim to study thecharacteristics of the SS in diabetic patients and todetermine
the predictive value of the SS as compared with the GRACE score for in-
hospital death.
Materials and methods: Our study analysed 1107 consecutive patients,
including 873 non-diabetic patients and 234 diabetic patients, hospitalized
for AMI in the intensive coronary care unit ofDijon from September 2011 to
December 2012 and whohad undergone coronary angiography. The SYNTAX
and GRACE scores were both calculated for each patient.
Results: Median SS was significantly higher in diabetic patients (11 (4-15)
vs. 8(4-15), p<0.001) than in non-diabetic patients. In multivariable analysis,
three predictive factors for a high SS were found: female (OR=0.62; 95%
CI=[0.45-0.89], (p=0.005)); age (OR=1.03; 95% CI=[1.02-1.04], (p<0.001))
and HDL-C (OR=0.28; 95%CI= [0.11-0.72], (p=0.008)). In-hospital mortality
increased significantly with increasing SS score quartiles (Q1: 2.9%,
Q2: 2.2%, Q3: 4.0%, and Q4: 9.7%, p<0.001). SSscore was associated with in-
hospital mortality, even after adjustment for confounding factors (GRACE
scoreand left ventricular ejection fraction).
Conclusion: In acute MI, the SS score is a reliable tool as it provides
objective information on the coronary network and is aprognostic factor in the
short term. Nonetheless, furtherstudies are needed to understand the influence
of risk factors such as diabetes or hyperglycemia on the initialand residual SS,
and to assess the impact of SS onpharmacological and other revascularization
strategies.
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